WABC Stock Analysis: Westamerica Bancorporation | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 1.363m USD | 12M Return: 28.8% | US9570901036 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 8.03M
EPS Trend: -94.4%
Qual. Beats: 7
Rev. Trend: -97.6%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Westamerica Bancorporation (WABC) is a bank holding company that operates through its subsidiary, Westamerica Bank, providing a range of banking products and services to individual and commercial customers in the United States. The company accepts deposits from local businesses, professionals, and retail customers-including savings, checking, and certificates of deposit-and offers a diverse loan portfolio that includes commercial loans, commercial and residential real estate, real estate construction, consumer installment loans, and indirect automobile loans. Its customer base primarily consists of small businesses, professionals, and consumers, reflecting a community banking model focused on local markets in Northern and Central California. Founded in 1884 and headquartered in San Rafael, California, the company was originally known as Independent Bankshares Corporation before adopting its current name in 1983.
Additional sector context: As a regional bank under the GICS classification, Westamerica operates within a highly regulated industry overseen by the Federal Reserve, FDIC, and state banking authorities, and it generates revenue primarily through the net interest margin between interest earned on loans and interest paid on deposits.
- Net interest margin compresses as Fed cuts rates
- Commercial real estate loan exposure raises credit concerns in California
- Deposit costs rise as competition for funding intensifies
| Net Income: 110.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.14 > 1.0 |
| NWC/Revenue: -76.11% < 20% (prev -1.04k%; Δ 968.6% < -1%) |
| CFO/TA 0.02 > 3% & CFO 115.5m > Net Income 110.7m |
| Net Debt (-4.56b) to EBITDA (151.9m): -30.00 < 3 |
| Current Ratio: 0.96 > 1.5 & < 3 |
| Outstanding Shares: last quarter (23.1m) vs 12m ago -8.75% < -2% |
| Gross Margin: 94.95% > 18% (prev 95.27%; Δ -0.32% > 0.5%) |
| Asset Turnover: 4.54% > 50% (prev 4.70%; Δ -0.16% > 0%) |
| Interest Coverage Ratio: 10.85 > 6 (EBIT TTM 148.9m / Interest Expense TTM 13.7m) |
| A: -0.03 (Total Current Assets 4.75b - Total Current Liabilities 4.96b) / Total Assets 5.79b |
| B: 0.10 (Retained Earnings 570.8m / Total Assets 5.79b) |
| C: 0.03 (EBIT TTM 148.9m / Avg Total Assets 5.85b) |
| D: 0.16 (Book Value of Equity 789.7m / Total Liabilities 5.00b) |
| Altman-Z'' = 0.43 = B |
| DSRI: 0.95 (Receivables 35.7m/39.4m, Revenue 265.9m/278.1m) |
| GMI: 1.00 (GM 95.27% / 94.95%) |
| AQI: 0.27 (AQ_t 0.18 / AQ_t-1 0.65) |
| SGI: 0.96 (Revenue 265.9m / 278.1m) |
| TATA: -0.00 (NI 110.7m - CFO 115.5m) / TA 5.79b) |
| Beneish M = -3.53 (Cap -4..+1) = AAA |
As of November 20, 2026, the stock is trading at USD 57.98 with a total of 160,995 shares traded. Over the past week, the price has changed by -2.78%, over one month by -2.76%, over three months by +0.59% and over the past year by +28.84%.
Current recommended Stop Loss: 54.90 (which is 5.3% or 2.4 ATR below the current price).
Westamerica Bancorporation has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold WABC.
- StrongBuy: 0
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 65 | 12.1% |
P/E Trailing = 12.722
P/E Forward = 21.097
P/S = 5.3994
P/B = 1.7395
P/EG = 4.6222
Revenue TTM = 265.9m USD
EBIT TTM = 148.9m USD
EBITDA TTM = 151.9m USD
Long Term Debt = unknown (0.0)
Short Term Debt = 139.1m USD (from shortTermDebt, last quarter)
Debt = 160.5m USD (from shortLongTermDebtTotal, last quarter) + Leases 21.4m
Net Debt = -4.56b USD (calculated: Debt 160.5m - CCE 4.72b)
Enterprise Value = 1.36b USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 10.85 (Ebit TTM 148.9m / Interest Expense TTM 13.7m)
EV/FCF = 12.13x (Enterprise Value 1.36b / FCF TTM 112.4m)
FCF Yield = 8.24% (FCF TTM 112.4m / Enterprise Value 1.36b)
FCF Margin = 42.26% (FCF TTM 112.4m / Revenue TTM 265.9m)
Net Margin = 41.63% (Net Income TTM 110.7m / Revenue TTM 265.9m)
Gross Margin = 94.95% ((Revenue TTM 265.9m - Cost of Revenue TTM 13.4m) / Revenue TTM)
Gross Margin QoQ = 94.65% (prev 94.98%)
Tobins Q-Ratio = 0.24 (Enterprise Value 1.36b / Total Assets 5.79b)
Interest Expense / Debt = 8.55% (Interest Expense 13.7m / Debt 160.5m)
Taxrate = 25.65% (38.2m / 148.9m)
NOPAT = 110.7m (EBIT 148.9m * (1 - 25.65%))
Current Ratio = 0.96 (Total Current Assets 4.75b / Total Current Liabilities 4.96b)
Debt / Equity = 0.20 (Debt 160.5m / totalStockholderEquity, last quarter 789.7m)
Debt / EBITDA = -30.00 (Net Debt -4.56b / EBITDA 151.9m)
Debt / FCF = -40.55 (Net Debt -4.56b / FCF TTM 112.4m)
Total Stockholder Equity = 864.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.89% (Net Income 110.7m / Total Assets 5.79b)
RoE = 12.80% (Net Income TTM 110.7m / Total Stockholder Equity 864.8m)
RoCE = 17.22% (EBIT 148.9m / Capital Employed (Equity 864.8m + L.T.Debt 0.0))
RoIC = 11.48% (NOPAT 110.7m / Invested Capital 964.1m)
WACC = 7.05% (E(1.36b)/V(1.52b) * Re(7.13%) + D(160.5m)/V(1.52b) * Rd(8.55%) * (1-Tc(0.26)))
Discount Rate = 7.13% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -95.98 | Cagr: -6.16%
[DCF] Terminal Value 74.20% ; FCFF base≈116.6m ; Y1≈108.7m ; Y5≈99.3m
[DCF] Fair Price = 265.3 (EV 1.57b - Net Debt -4.56b = Equity 6.13b / Shares 23.1m; r=8.35% [WACC [floored]]; 5y FCF grow -8.49% → 2.50% )
EPS Correlation: -94.37 | EPS CAGR: -11.13% | SUE: 2.59 | # QB: 7
Revenue Correlation: -97.63 | Revenue CAGR: -8.93% | SUE: 0.17 | # QB: 0
EPS current Quarter (2027-03-31): EPS=1.21 | Chg30d=+5.24% | Revisions=+40% | Analysts=2
EPS current Year (2026-12-31): EPS=4.74 | Chg30d=+2.16% | Revisions=+40% | GrowthEPS=+4.8% | GrowthRev=-1.8%
EPS next Year (2027-12-31): EPS=4.94 | Chg30d=+5.67% | Revisions=+40% | GrowthEPS=+4.3% | GrowthRev=+1.8%
[Analyst] Revisions Ratio: +67% (up=6, down=0)